Nº
(%) |
Histopathological findings in the duodenal biopsy
N=306 |
CD
300
(98) |
DGM
31
(10.1) |
Act D
49
(16.1) |
Hp D
6
(1.9) |
V:C AR
185
(60.4) |
HC
182
(59.4) |
SED
77
(25.1) |
BBL
34
(11.1) |
IEL AC
9
(2.9) |
DU
11
(3.5) |
With Hp
n=95 |
95
(31.6) |
15
(48.4) |
19
(38.8) |
6
(100) |
53
(28.6) |
26
(24.2) |
39
(50.6) |
19
(55.8) |
3
(33.3) |
7
(63.6) |
Without Hp
n=211 |
205
(68.4) |
16
(51.6) |
30
(61.2) |
0
(0) |
132
(71.4) |
81
(75.8) |
38
(49.4) |
15
(44.2) |
6
(66.7) |
4
(36.4) |
OR
CI |
2.76
0.33-23.2 |
2.2
1.02-4.8 |
1.5
0.8-2.84 |
14.3
1.7-120 |
.755
0.46-1.23 |
0.6
0.33-0.95 |
3.17
1.85-5.43 |
3.26
1.57-6.75 |
1.114
0.27-4.55 |
4.116
1.17-14.4 |
| p* |
0.352 |
0.045 |
0.2 |
0.001** |
0.26 |
0.032 |
0.001 |
0.001 |
0.881** |
0.018** |
Helicobacter pylori; OR, odds ratio; CI, confidence interval; CD, chronic duodenitis; DGM, duodenal gastric metaplasia; Act D, active duodenitis; HpD, duodenal Helicobacter pylori; V:C AR, villous:crypta alteration ratio; HC, crypt’s hyperplasia; SED, superficial enterocitos damage; BBL, brush border loss; IEL AC, intraepithelial lymphocytes, abnormal count; DU, duodenal ulcer.*p c2. ** p. Fisher’s exact test (wait frequency < 5). |
